Cargando…

Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines

Neurons from mouse models of Huntington’s disease (HD) exhibit altered electrophysiological properties, potentially contributing to neuronal dysfunction and neurodegeneration. The renin–angiotensin system (RAS) is a potential contributor to the pathophysiology of neurodegenerative diseases. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: De Mello, Walmor C., Gerena, Yamil, Ayala-Peña, Sylvette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442183/
https://www.ncbi.nlm.nih.gov/pubmed/28596754
http://dx.doi.org/10.3389/fendo.2017.00108
_version_ 1783238353504698368
author De Mello, Walmor C.
Gerena, Yamil
Ayala-Peña, Sylvette
author_facet De Mello, Walmor C.
Gerena, Yamil
Ayala-Peña, Sylvette
author_sort De Mello, Walmor C.
collection PubMed
description Neurons from mouse models of Huntington’s disease (HD) exhibit altered electrophysiological properties, potentially contributing to neuronal dysfunction and neurodegeneration. The renin–angiotensin system (RAS) is a potential contributor to the pathophysiology of neurodegenerative diseases. However, the role of angiotensin II (Ang II) and angiotensin (1-7) has not been characterized in HD. We investigated the influence of Ang II and angiotensin (1-7) on total potassium current using immortalized progenitor mutant huntingtin-expressing (Q111) and wild-type (Q7) cell lines. Measurements of potassium current were performed using the whole cell configuration of pCLAMP. The results showed that (1) the effect of Ang II administered to the bath caused a negligible effect on potassium current in mutant Q111 cells compared with wild-type Q7 cells and that intracellular administration of Ang II reduced the potassium current in wild type but not in mutant cells; (2) the small effect of Ang II was abolished by losartan; (3) intracellular administration of Ang II performed in mutant huntingtin-expressing Q111 cells revealed a negligible effect of the peptide on potassium current; (4) flow cytometer analysis indicated a low expression of Ang II AT1 receptors in mutant Q111 cells; (5) mutant huntingtin-expressing striatal cells are highly sensitive to Ang (1-7) and that the effect of Ang (1-7) is related to the activation of Mas receptors. In conclusion, mutant huntingtin-expressing cells showed a negligible effect of Ang II on potassium current, a result probably due to the reduced expression of AT1 receptors at the surface cell membrane. In contrast, administration of Ang (1-7) to the bath showed a significant decline of the potassium current in mutant cells, an effect dependent on the activation of Mas receptors. Ang II had an intracrine effect in wild-type cells and Ang (1-7) exerted a significant effect in mutant huntingtin-expressing striatal cells.
format Online
Article
Text
id pubmed-5442183
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-54421832017-06-08 Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines De Mello, Walmor C. Gerena, Yamil Ayala-Peña, Sylvette Front Endocrinol (Lausanne) Endocrinology Neurons from mouse models of Huntington’s disease (HD) exhibit altered electrophysiological properties, potentially contributing to neuronal dysfunction and neurodegeneration. The renin–angiotensin system (RAS) is a potential contributor to the pathophysiology of neurodegenerative diseases. However, the role of angiotensin II (Ang II) and angiotensin (1-7) has not been characterized in HD. We investigated the influence of Ang II and angiotensin (1-7) on total potassium current using immortalized progenitor mutant huntingtin-expressing (Q111) and wild-type (Q7) cell lines. Measurements of potassium current were performed using the whole cell configuration of pCLAMP. The results showed that (1) the effect of Ang II administered to the bath caused a negligible effect on potassium current in mutant Q111 cells compared with wild-type Q7 cells and that intracellular administration of Ang II reduced the potassium current in wild type but not in mutant cells; (2) the small effect of Ang II was abolished by losartan; (3) intracellular administration of Ang II performed in mutant huntingtin-expressing Q111 cells revealed a negligible effect of the peptide on potassium current; (4) flow cytometer analysis indicated a low expression of Ang II AT1 receptors in mutant Q111 cells; (5) mutant huntingtin-expressing striatal cells are highly sensitive to Ang (1-7) and that the effect of Ang (1-7) is related to the activation of Mas receptors. In conclusion, mutant huntingtin-expressing cells showed a negligible effect of Ang II on potassium current, a result probably due to the reduced expression of AT1 receptors at the surface cell membrane. In contrast, administration of Ang (1-7) to the bath showed a significant decline of the potassium current in mutant cells, an effect dependent on the activation of Mas receptors. Ang II had an intracrine effect in wild-type cells and Ang (1-7) exerted a significant effect in mutant huntingtin-expressing striatal cells. Frontiers Media S.A. 2017-05-24 /pmc/articles/PMC5442183/ /pubmed/28596754 http://dx.doi.org/10.3389/fendo.2017.00108 Text en Copyright © 2017 De Mello, Gerena and Ayala-Peña. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
De Mello, Walmor C.
Gerena, Yamil
Ayala-Peña, Sylvette
Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
title Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
title_full Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
title_fullStr Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
title_full_unstemmed Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
title_short Angiotensins and Huntington’s Disease: A Study on Immortalized Progenitor Striatal Cell Lines
title_sort angiotensins and huntington’s disease: a study on immortalized progenitor striatal cell lines
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442183/
https://www.ncbi.nlm.nih.gov/pubmed/28596754
http://dx.doi.org/10.3389/fendo.2017.00108
work_keys_str_mv AT demellowalmorc angiotensinsandhuntingtonsdiseaseastudyonimmortalizedprogenitorstriatalcelllines
AT gerenayamil angiotensinsandhuntingtonsdiseaseastudyonimmortalizedprogenitorstriatalcelllines
AT ayalapenasylvette angiotensinsandhuntingtonsdiseaseastudyonimmortalizedprogenitorstriatalcelllines